Volume 15, Number 12—December 2009
Dispatch
Mopeia Virus–related Arenavirus in Natal Multimammate Mice, Morogoro, Tanzania
Table 1
Genus | Antibody detection† by region (no. positive/no. tested) |
Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Arusha | Iringa | Lindi | Mbeya | Morogoro | Mtwara | Ruvuma | Songea | Tanga | ||
Acomys | – | 0/3 | 0/2 | 0/2 | 0/57 | 0/2 | – | – | – | 0/66 |
Aethomys | – | 0/3 | 0/4 | – | 0/23 | 0/11 | 0/7 | 0/8 | – | 0/56 |
Arvicanthis | 0/13 | 6/30 | – | – | – | – | – | – | 0/87 | 6/130 |
Cricetomys | – | – | – | – | 0/35 | – | – | – | – | 0/35 |
Lemniscomys | 0/5 | 1/2 | 1/2 | – | 1/30 | 0/2 | 0/1 | – | – | 3/42 |
Lophuromys | 0/3 | 0/1 | – | – | 0/3 | – | – | – | 0/7 | 0/14 |
Mastomys | 7/39 | 0/17 | 1/120 | 0/12 | 181/1,054‡ | 0/81 | 0/8 | 0/25 | 0/82 | 189/1,438 |
Mus | – | 0/1 | – | 0/1 | 1/47 | – | – | – | – | 1/49 |
Praomys | – | 0/3 | – | 0/1 | 0/1 | – | – | – | 0/1 | 0/6 |
Rattus | – | – | 0/24 | 0/1 | 0/49 | 0/20 | 0/3 | 0/15 | 0/196 | 0/308 |
Tatera | 0/1 | 0/1 | 0/32 | – | 0/127 | 0/69 | 0/11 | 0/3 | – | 0/244 |
Uranomys | – | – | – | – | 0/11 | – | – | – | – | 0/11 |
Sciuridae | – | – | 0/13 | – | 0/2 | – | 0/2 | – | 0/10 | 0/27 |
Crocidura | – | – | – | – | 1/14 | – | – | – | – | 1/14 |
Petrodomus | – | – | 0/9 | – | – | 0/18 | – | – | – | 0/27 |
13 other genera |
– |
0/1 |
0/2 |
0/7 |
0/21 |
0/20 |
– |
– |
0/2 |
0/53 |
Total | 7/61 | 7/62 | 2/208 | 0/24 | 184/1,474 | 0/223 | 0/32 | 0/51 | 0/385 | 200/2,520 |
*Positive samples as well as the respective sampling sites and animals are indicated in boldface.
†Immunofluorescent antibody (IFA) assay was performed with Lassa virus–infected cells (cut-off titer 16).
‡Fifty IFA assay–positive serum samples were randomly selected and tested by immunoblotting. Presence of African arenavirus–specific antibodies, as defined by reactivity with Lassa virus nucleoprotein and glycoprotein 2, was confirmed in 47 serum specimens.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.